Clinical Trials in Maryland

Showing 21701-21720 of 23,284 trials

Using SCOUT Noninvasive AGE Measurements to Forecast Diabetes Complications

NCT01415115

The trial is designed as a feasibility study to determine the correlation of noninvasive measurements of AGE with the SCOUT device to diabetes complications.

Type 1 DiabetesType 2 Diabetes

VeraLight, Inc.250 participantsStarted Mar 2007

Hyattsville, Maryland, United States

COMPLETEDPhase 312 miles

12-week Efficacy of Indacaterol

NCT01072448

This 12-week study evaluated the efficacy and safety of indacaterol versus placebo.

Chronic Obstructive Pulmonary Disease

Novartis323 participantsStarted Jan 2010

Peoria, Arizona, United States • Pine Bluff, Arkansas, United States • Buena Park, California, United States +59 more locations

Using SCOUT Noninvasive AGE Measurements to Forecast Diabetes Complications

12-week Efficacy of Indacaterol

Find Trials by Condition in Maryland

Efficacy and Safety of Indacaterol Plus Tiotropium Versus Tiotropium Alone in Patients With Chronic Obstructive Pulmonary Disease

Comparison of Raloxifene and Lasofoxifene - A Randomized, Blinded Study of These Drugs and Placebo on Bone Loss

Interleukin-2 Plus Antiretroviral Therapy for HIV-Infected Patients With Low CD4+ Counts (SILCAAT Study)

Zenapax to Treat Multiple Sclerosis

A Comparison of Zidovudine (AZT) and Stavudine in HIV-Infected Patients

B-19 Parvovirus Vaccine Study

Efficacy and Safety of TMS for the Preemptive Treatment of Migraine With Aura

Use of Pulsed Electromagnetic Fields for Postoperative Knee Pain

Bacterial Pulmonary Infection in PICU

Two-Dose Methotrexate for Ectopic Pregnancy

Safety & Radiation Distribution Study of Cotara® in Patients With Recurrent Glioblastoma Multiforme

Study of MB07811 in Subjects With Hypercholesterolemia

Efficacy, Safety and Pharmacokinetics of Different Regimens of Indacaterol

Trivalent rHA Dose Escalation Study in Elderly Subjects

Efficacy and Safety of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD) Using Salmeterol as Active Control

The Effect of Indacaterol on Exercise Endurance in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease

Chemotherapy in Treating Patients With Non-Small Cell Lung Cancer

Efficacy, Safety, and Tolerability of Once Daily Indacaterol in Chronic Obstructive Pulmonary Disease (COPD) Using Formoterol Twice Daily as Active Control